Geron | Passività Correnti



Current Liabilities Cambiamento Data
Amgen USD 23.1B 2.79B 2024-12
Bio Techne USD 161.26M 19.13M 2024-12
Cassava Sciences USD 11.75M 45.28M 2024-12
Cytokinetics USD 179.67M 69.86M 2024-12
Exelixis USD 403.77M 9.42M 2025-01
Genmab DKK 5.31B 723M 2024-12
Geron USD 88.3M 49.64M 2024-12
Gilead Sciences USD 12B 279M 2024-12
Incyte USD 1.89B 244.96M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Novartis USD 28.69B 560M 2024-12



Geron Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.